Updates on Aspergillus, Pneumocystis and other opportunistic pulmonary mycoses

Jose Curbelo1, Jose María Galván1, Javier Aspa2

  • 1Servicio de Medicina Interna, Instituto Princesa de Investigación IIS-IP, Madrid, España.

Insights

Fungal infections (mycoses) are dangerous, especially in immunocompromised patients. This review highlights key diagnostic advances to improve early detection and treatment of invasive fungal infections.

Area of Science:

  • Medical Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Mycoses pose significant health risks, with increasing prevalence due to immunosuppressive therapies and life support.
  • Compromised immune response is a primary risk factor for opportunistic fungal infections.
  • Early diagnosis and treatment are critical for improving patient outcomes.

Purpose of the Study:

  • To review patient profiles susceptible to mycoses.
  • To elucidate the role of the immune system in fungal infections.
  • To detail major accepted diagnostic developments for fungal infections.

Main Methods:

  • Literature review focusing on patient susceptibility, immune response, and diagnostic advancements.
  • Analysis of current diagnostic techniques and their limitations.
  • Synthesis of accepted diagnostic developments in medical mycology.

Main Results:

  • Identification of key patient populations at risk for invasive mycoses.
  • Understanding the immunological basis of susceptibility to fungal infections.
  • Overview of established and emerging diagnostic tools for mycoses.

Conclusions:

  • Accurate diagnosis of mycoses remains challenging, often requiring integration of clinical, radiological, and microbiological data.
  • Distinguishing colonization from invasive infection is a critical diagnostic hurdle.
  • Advancements in diagnostic methods are crucial for timely and effective management of fungal infections.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
89
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
2.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K